Though Systolic BP Seems More Important, Diastolic BP Should Not Be Disregarded

Systolic hypertension is more often associated to cardiovascular events. However, diastolic blood pressure should not be disregarded, since it can also predict even worse outcomes.

Oportunidades perdidas en pacientes con enfermedad vascular periférica

Although systolic blood pressure is very frequently associated to adverse cardiovascular events, by no means should diastolic blood pressure be considered unimportant.

Such is the message of this study recently published in NEJM including data from more than 1.3 million outpatients, which shows that both systolic and diastolic hypertension are independently associated to cardiovascular events in the long run (acute myocardial infarction, ischemic or hemorrhagic stroke) regardless the type of blood pressure we might be focusing on.

Diastolic pressure should not be ignored, and we should focus on both BP goals (systolic and diastolic) for both hypertension diagnosis and treatment, to maximize the chances of therapy and effectively reduce population risk. According to the study authors, the AHA/ACC goals are reasonable and well founded, which is why they suggest aggressive treatment, especially when it comes to higher risk patients.


Read also: Dietary Supplements and Diets Show No Impact on Cardiovascular Risk.


They believe the J shaped curve should be of no concern.

The analysis included 36.8 million registries on blood pressure automatically measured. Using 140/90 as threshold, 18.9% presented hypertension, but when using 130/80 the incidence increased to 43.5%!!!

Regardless the BP definition we might choose, both systolic and diastolic pressure are independently associated to adverse events at 8 year follow up.

The correlation was stronger for systolic blood pressure.


Read also: Supervised Exercise and Revascularization for Intermittent Claudication.


The authors also explored the J shape curve previously observed between diastolic BP and events. This non-adjusted analysis showed increased risk both for peak and valley thresholds, but when adjusting by age, race and other comorbidities, the risk at the bottom of the curve disappeared.

According to this study, the J shape in this population (mostly healthy, mean age 53) is not a problem, so we should be more aggressive in trying to reach the proposed goals with no regard of the J curve, since after adjusting for variables, the risk in the lowest quartile disappears.

Título original: Effect of systolic and diastolic blood pressure on cardiovascular outcomes.

Referencia: Flint AC et al. N Engl J Med. 2019;381:243-251.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....